<?xml version="1.0" encoding="UTF-8"?>
<ref id="B4-pharmaceutics-11-00040" class="ref">
 <label class="label">4.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Ma</surname>
    <given-names class="given-names">T.K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kam</surname>
    <given-names class="given-names">K.K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yan</surname>
    <given-names class="given-names">B.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lam</surname>
    <given-names class="given-names">Y.Y.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: Current status</article-title>
  <source class="source">Br. J. Pharmacol.</source>
  <year class="year">2010</year>
  <volume class="volume">160</volume>
  <fpage class="fpage">1273</fpage>
  <lpage class="lpage">1292</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1111/j.1476-5381.2010.00750.x</pub-id>
  <?supplied-pmid 20590619?>
  <pub-id pub-id-type="pmid" class="pub-id">20590619</pub-id>
 </element-citation>
</ref>
